As a result of the improvements observed in white and brown adipose tissues and in liver, both HFD‐fed and ob/ob mice treated with liver‐targeted FGF21 gene therapy showed a remarkable increase in insulin sensitivity, clearly demonstrated by the correction of hyperinsulinemia and the improved performance in the ITT and GTT. The gene discussed is FGF21; the disease is Hyperinsulinemia.